Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene

Cell Death and Differentiation

Volumn 7, Issue 5, 2000, Pages 439-446

  Eguchi, H ^a   Suga, K ^a   Saji, H ^b   Toi, M ^b   Nakachi, K ^a   Hayashi, S I ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Apoptosis; Bak; Breast cancer; Estrogen receptor

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL X;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CELL TRANSFORMATION; CLINICAL ARTICLE; COLONY FORMATION; EXPRESSION VECTOR; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIGENE FAMILY; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0034015434     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400675     Document Type: Article

References (35)

1. Kroemer G (1997) The proto-oncogenic Bcl-2 and its role in regulating apoptosis. Nature Medicine 3: 614-620
2. Lu QL, Abel P, Foster CS and Lalani EN (1996) bcl-2: Role in epithelial differentiation and oncogenesis. Human Pathology 27: 102-109
3. Tsujimoto Y and Croce CM (1986) Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 83: 5214-5218
4. Gasparini G, Barbareschi M, Doglioni C, Palma PD, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P, Pezzella F and Harris AL (1995) Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clinic. Cancer Res. 1: 189-198
5. Joensuu H, Pylkkänen L and Toikkanen S (1994) Bcl-2 protein expression and long-term survival in breast cancer. Am. J. Pathol. 145: 1191-1198
6. Hellemans P, van Dam PA, Weyler J, van Oosterom AT, Puytaert P and Van Marck E (1995) Prognostic value of bcl-2 expression in invasive breast cancer. Br. J. Cancer 72: 354-360
7. Barbareschi M, Caffo O, Veronese S, Leek RD, Fina P, Fox S, Bonzanini M, Girlando S, Morelli L, Eccher C, Pezzella F, Doglioni C, Palma PD and Harris A (1996) Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up. Hum. Pathol. 27: 1149-1155
8. Doglioni C, Dei Tos AP, Laurino L, Chiarelli C, Barbareschi M and Viale G (1994) The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows. Arch. 424: 47-51
9. Gee JMW, Robertson JFR, Ellis IO, Willsher P, McClelland RA, Hoyle HB, Kyme SR, Finlay P, Blamey RW and Nicholson RI (1994) Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int. J. Cancer 59: 619-628
10. Teixeira C, Reed JC and Pratt MAC (1995) Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55: 3932-3907
11. Miyashita T, Harigai M, Hanada M and Reed JC (1994) Identification of a p53-Dependent dependent negative response element in the bcl-2 gene. Cancer Res. 15: 3131-3135
12. McGuire WL (1978) Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Sem. Oncol. 5: 428-433
13. Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, Nordling S and Reed JC (1995) Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinomas Cancer Res. 55: 4471-4478
14. Veronese S, Mauri FA, Caffo O, Scaioli M, Aldovini D, Perrone G, Galligioni E, Doglioni C, Palma PD and Barbareschi M (1998) Bax immunohistochemical expression in breast carcinoma: A study with long term follow-up. Int. J. Cancer 79: 13-18
15. Farrow SN, White JH, Martinou I, Raven T, Pun KT, Grinham CJ, Martinou JC and Brown R (1995) Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374: 731-733
16. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI and Guild BC (1995) Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374: 733-736
17. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD and Barr PJ (1995) Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374: 736-739
18. Ink B, Zörnig M, Baum B, Hajibagher N, James C, Chittendem T and Evan G (1997) Human Bak induces cell death in Schizosaccharomyces pombe with morphological changes similar to those with apoptosis in mammalian cells Mol. Cell. Biol. 17: 2468-2474
19. Tao W, Kurschner C and Morgan JI (1997) Modulation of cell death in yeast by the Bcl-2 family of proteins. J. Biol. Chem. 272: 15547-15552
20. Krajewska M, Moss SF, Krajewska S, Song K, Holt pR and Reed JC (1996) Elevated expression of Bcl-x and reduced Bak in primary colorectal adenocarcinoma. Cancer Res. 56: 2422-2427
21. Krajewska M, Fenoglio-Preiser CM, Krajewski S, Song K, Macdonald JS. Stemmerman G and Reed JC (1996) Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am. J. Pathol. 149: 1449-1457
22. Zapata JM, Krajewska M, Krajewski S, Huang RP, Takayama S, Wang HG, Adamson E and Reed JC (1998) Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors. Breast Cancer Res and Treatment 47: 129-140
23. Leung LK and Wang TT (1999) Paradoxical regulation of Bcl-2 family proteins by 17/β-oestradiol in human breast cancer cells MCF-7. Br. J. Cancer 81: 387-392
24. Herberg JA, Phillips S, Beck S, Jones T, Sheer D, Wu JJ, Prochazka V, Barr PJ. Kiefer MC and Trowsdale J (1998) Genomic structure and domain organization of the human Bak gene. Gene 211: 87-94
25. Kerangueven F, Noguchi T, Coulier F, Allione F, Wargniez V, Simony-Lafontaine J, Longy M, Jacquemier J, Sobol H, Eisinger F and Birnbaum D (1997) Genomewide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res. 15: 5469-5474
26. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S and Gustafsson JA (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93: 5925-5930
27. Ossina NK, Cannas A, Powers VC, Fitzpatrick PA, Knight JD, Gillbert JR, Shekhtman EM, Tomei LD, Umansky SR and Kiefer MC (1997) Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J. Biol. Chem. 272: 16351-16357
28. Hayashi SI, Imai K, Suga K, Kurihara T, Higashi Y and Nakachi K (1997) Two promoters in expression of estrogen receptor messenger RNA in human breast cancer. Carcinogenesis 18: 459-464
29. Hayashi SI, Tanimoto K, Hajoro-Nakanishi K, Tsuchiya E, Kurosumi M, Higashi Y, Imai K, Suga K and Nakachi K (1997) Abnormal FHIT transcripts in human breast carcinomas: A clinicopathological and epidemiological analysis of 61 Japanese cases. Cancer Res. 57: 1981-1985
30. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159
31. Hayashi SI, Watanabe J, Nakachi K, Eguchi H, Gotoh O and Kawajiri K (1994) Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 15: 801-806
32. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G and Thompson CB (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608
33. Oltvai Z, Milliman C and Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619
34. Ercolani L, Florence B, Denaro M and Alexander M (1988) Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J. Biol. Chem. 263: 15335-15341
35. Hayashi SI, Hajiro-Nakanishi K, Makino Y, Eguchi H, Yodoi J and Tanaka H (1997) Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res. 25: 4035-4040